Toradol
CAS No. 74103-07-4
Toradol ( Toradol )
产品货号. M15828 CAS No. 74103-07-4
Ketorolac (Ketorolac tromethamine, Toradol) 是一种非选择性 COX 抑制剂,具有很强的镇痛活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ¥147 | 有现货 |
|
| 100MG | ¥196 | 有现货 |
|
| 500MG | ¥446 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥125 | 有现货 |
|
生物学信息
-
产品名称Toradol
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ketorolac (Ketorolac tromethamine, Toradol) 是一种非选择性 COX 抑制剂,具有很强的镇痛活性。
-
产品描述Ketorolac (Ketorolac tromethamine, Toradol) is a non-selective COX inhibitor with strong analgesic activity.(In Vitro):Ketorolac is a non-steroidal anti-inflammatory agent, acting as a nonselective COX inhibitor, with IC50s of 20 nM for COX-1 and 120 nM for COX-2.(In Vivo):Ketorolac tromethamine (0.4%) causes nearly complete inhibition on LPS endotoxin-induced increases in FITC-dextran in the anterior chamber, and increases in aqueous PGE2 concentrations in the aqueous humor in rabbits. Ketorolac (30 mg/kg, i.v.) rapidly reverses hyperalgesia in rats. Ketorolac also reduces carrageenan-induced hyperalgesia and paw PG production, and causes reduction in PGE2 levels in rats. Ketorolac (4 mg/kg/day, p.o.) has no detrimental effect in the volume fraction of bone trabeculae formed inside the alveolar socket in rats. Ketorolac (60 μg/10 μL) reduces the histological changes such as ischemic cell death, including cytoplasmic eosinophilia with disintegration of cytoarchitecture and nuclear pyknosis in rats. Ketorolac also effectively reduces neuronal death and improves hindlimb motor function, and the long-term survival is similar to that in the control group.
-
体外实验Ketorolac is a non-steroidal anti-inflammatory agent, acting as a nonselective COX inhibitor, with IC50s of 20 nM for COX-1 and 120 nM for COX-2.
-
体内实验Ketorolac tromethamine (0.4%) causes nearly complete inhibition on LPS endotoxin-induced increases in FITC-dextran in the anterior chamber, and increases in aqueous PGE2 concentrations in the aqueous humor in rabbits.Ketorolac (30 mg/kg, i.v.) rapidly reverses hyperalgesia in rats. Ketorolac also reduces carrageenan-induced hyperalgesia and paw PG production, and causes reduction in PGE2 levels in rats. Ketorolac (4 mg/kg/day, p.o.) has no detrimental effect in the volume fraction of bone trabeculae formed inside the alveolar socket in rats. Ketorolac (60 μg/10 μL) reduces the histological changes such as ischemic cell death, including cytoplasmic eosinophilia with disintegration of cytoarchitecture and nuclear pyknosis in rats. Ketorolac also effectively reduces neuronal death and improves hindlimb motor function, and the long-term survival is similar to that in the control group.
-
同义词Toradol
-
通路Chromatin/Epigenetic
-
靶点COX
-
受体COX-1| COX-2
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number74103-07-4
-
分子量376.4
-
分子式C19H24N2O6
-
纯度>98% (HPLC)
-
溶解度Ethanol: 75 mg/mL warmed (293.8 mM); DMSO: 75 mg/mL (293.8 mM)
-
SMILESO=C(C1C2=CC=C(C(C3=CC=CC=C3)=O)N2CC1)O.OCC(CO)(N)CO
-
化学全称2-amino-2-(hydroxymethyl)propane-1,3-diol 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Hocherl K, et al. Am J Physiol Renal Physiol. 2002 Aug;283(2):F294-30
产品手册
关联产品
-
Polmacoxib
Polmacoxib (CG-100649) 是一种新型 NSAID,可抑制 COX-2 和碳酸酐酶 (CA)-I/-II。
-
Loxoprofen
洛索洛芬是一种非甾体抗炎化合物。
-
Seratrodast
Seratrodast(AA 2414)是一种抗哮喘剂和一种血栓素 A2 受体 (TP) 拮抗剂。
021-51111890
购物车()
sales@molnova.cn

